What is the molecular cause of synovial sarcoma?

Written by Ebony Torrington, Future Science Group

Researchers have discovered how an abnormal protein disrupts and misdirects the control of gene expression in cells that contribute to the malignant growth of synovial sarcoma tumors. This new understanding could aid the development of drugs to treat synovial sarcoma. Researchers at the Dana-Farber Cancer Institute (MA, USA) have discovered how an abnormal protein misdirects and disrupts the control of gene expression in cells. The study suggests that the protein causes the abnormal activation of genes that are normally repressed, which contributes to the malignant growth of synovial sarcoma tumors. The scientists say that these new understandings could help develop...

To view the full article, please register now for access

It's completely free